Q&A with Avingtrans CEO, Steve McQuillan & CFO Stephen King
In this interview, CEO Steve McQuillan & CFO Stephen King of take me through today’s record H1’24 results and in line outlook – including:
00:00 What does and its secular growth drivers
05:00 Orderbook & financial highlights
09:40 Update on Adaptix, Magnetica and broader medical division
14:55 Group resilience from Trump tariffs
16:20 Possible corporate exits over the next 12-18 month
22:00 Key closing messages
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.